Tin tức & Cập nhật
Xem bài viết Nhi khoa
Xem
Chỉ hiển thị Multimedia

Glecaprevir/pibrentasvir shows favourable efficacy signals for paediatric HCV
10 Jul 2024
bởiAudrey Abella
Findings from the ongoing POLAC project demonstrate that treatment with the pangenotypic regimen comprising glecaprevir/pibrentasvir (GLE/PIB) for 8 weeks is highly effective against chronic hepatitis C virus (HCV) infection in children and adolescents. This regimen also showed a good safety profile.
10 Jul 2024







